Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03662295 · ClinicalTrials.gov registry record

Stroke-like Migraine Attacks After Radiation Treatment (SMART) Syndrome Language Intervention

A clinical trial of Aphasia and Migraine Disorders, sponsored by Quality Living.

Completed
Registry status
1
Enrollment target
1
Study location

NCT03662295 is a study of Aphasia and Migraine Disorders that has completed, run by Quality Living. The registered enrollment target is 1 participants, below the 83-participant average among 42 other Aphasia trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03662295, a study of Aphasia and Migraine Disorders, has completed, sponsored by Quality Living.

COMPLETED
Registry status
1 participants
Enrollment target
1
Study location

Study Summary

Stroke-like migraine attacks after radiation therapy-also known as SMART syndrome-constitute a rare condition typically characterized by headache, seizures, vision abnormalities, hemiparesis, and aphasia. The condition usually resolves within a few days or weeks of onset with no residual impairments. However, resolution in some cases extends over a period of months rather than weeks and may be incomplete. The purpose of this case report is to provide an in-depth description of the progression of changes in cognitive and language functioning for a person exhibiting SMART syndrome characterized by slow recovery.

Interventions

  • BEHAVIORAL Language treatment

Study Locations (1)

Nebraska

  • Quality Living, Inc. - Omaha

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2018-09-03
Est. Completion 2019-11-13

Sponsor

Quality Living

4 total trials

What the Registry Record Tells You About NCT03662295

The ClinicalTrials.gov registry entry for NCT03662295 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 83-participant average among 42 other Aphasia trials with a reported enrollment target (99% lower). The listed sponsor is Quality Living, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Aphasia appearing as the primary indexed condition, and to 1 intervention - of which Language treatment is the first listed.

NCT03662295 reports 1 study location spanning 1 distinct geographic area - top geographies include Nebraska.

Frequently Asked Questions

What is clinical trial NCT03662295 about?

NCT03662295 is a clinical study titled "Stroke-like Migraine Attacks After Radiation Treatment (SMART) Syndrome Language Intervention". Stroke-like migraine attacks after radiation therapy-also known as SMART syndrome-constitute a rare condition typically characterized by headache, seizures, vision abnormalities, hemiparesis, and aphasia. The condition usually resolves within a few days or weeks of onset with no residual impairments...

What is the current status of trial NCT03662295?

This trial is currently completed. The enrollment target is 1 participants. The study started on 2018-09-03. Estimated completion is 2019-11-13.

What conditions does trial NCT03662295 study?

This clinical trial studies the following conditions: Aphasia, Migraine Disorders.

What interventions are being tested in trial NCT03662295?

The interventions under investigation include: Language treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT03662295?

This trial is sponsored by Quality Living, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03662295 being conducted?

This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aphasia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.